Long-Read Whole Genome Sequencing Test Gets Regulatory Nod
Azenta, Inc. has launched a long-read whole genome sequencing test for clinical use, offering accuracy in detecting genetic variants.
Read MorePosted by Chris Wolski | Nov 18, 2024 | Molecular Diagnostics |
Azenta, Inc. has launched a long-read whole genome sequencing test for clinical use, offering accuracy in detecting genetic variants.
Read MorePosted by Chris Wolski | Nov 18, 2024 | Lung Cancer |
Researchers have developed a novel testing strategy for mesothelioma cancer, focusing on detecting chromosomal rearrangements in cancer DNA.
Read MorePosted by Chris Wolski | Nov 18, 2024 | Disease States |
Discovering mutations in the FLVCR1 gene, provided a genetic diagnosis for 30 individuals with previously undiagnosed conditions.
Read MorePosted by Chris Wolski | Nov 18, 2024 | Lab Automation |
Artificial Intelligence enables development of new diagnostic and prognostic models, supporting the move toward personalized medicine.
Read MorePosted by Andy Lundin | Nov 14, 2024 | Cancer |
Researchers developed an AI tool that predicts tumor gene activity from standard biopsy images, potentially speeding up cancer diagnostics.
Read More